基于阳离子荧光共轭聚合物和核酸适体探针的蛋白质检测新方法

以核酸适体为识别分子, 阳离子荧光共轭聚合物为报告分子, 建立了一种蛋白质检测新方法. 修饰有荧光熄灭基团的核酸适体探针通过静电作用与阳离子荧光共轭聚合物结合, 导致后者荧光熄灭. 当加入靶蛋白后, 核酸适体探针与其特异性结合, 荧光熄灭基团与阳离子荧光共轭聚合物远离, 聚合物荧光信号得以恢复. 实验结果表明, 荧光恢复程度与靶蛋白的浓度正相关. 采用该方法检测凝血酶的线性范围为17～40 nmol/L.     

Aptamer-based Electrochemical Biosensors for Highly Selective and Quantitative Detection of Adenosine

A new adenosine biosensor based on aptamer probe is introduced in this article. An amino-labeled aptamer probe was immobilized on the gold electrode modified with an o-phenylenediamine electropolymerized film. When adenosine is bound specifically to the aptamer probe, the interface of the biosensor is changed, resulting in the decrement of the peak current. The response current is proportional to the amount of adenosine in sample. The used electrode can be easily regenerated in hot water. The proposed biosensor represents a linear response to adenosine over a concentration range of 1.0x 10^-7-l.0x10^-4 mol/L with a detection limit of 1.0xl0^-8 mol/L. The presented biosensor exhibits a nice specificity towards adenosine. It offers a promising approach for adenosine assay due to its excellent electrochemical properties that are believed to be very attractive for electrochemical studies and electroanalytical applications.     

Fast functionalization of silver decahedral nanoparticles with aptamers for colorimetric detection of human platelet-derived growth factor-BB

Aptamer-silver decahedral nanoparticles (Ag₁₀NPs-aptamer) based detection was developed for protein. Ag₁₀NPs were synthesized by photochemical method. The advantage of Ag₁₀NPs was its tolerance of NaCl which facilitates the functionalization of silver nanoparticles with all kinds of ssDNA. Attaching aptamers to Ag₁₀NPs could be achieved within 2 h, much faster than traditional methods. Human platelet-derived growth factor-BB (PDGF-BB) was used as a model protein to test the binding capacity of aptamers attached on Ag₁₀NPs. Our data showed that the aptamer-Ag₁₀NPs conjugates were successful in detecting human PDGF-BB. Furthermore, we developed an aptamer-Ag₁₀NPs conjugates-based colorimetric sensor to detect PDGF-BB. The results showed a linear relationship between PDGF-BB concentrations (5 ng mL⁻¹–200 ng mL⁻¹) and ΔOD with excellent detection specificity in serum. Therefore, the sensor based on aptamer-Ag₁₀NPs conjugates was highly effective and sensitive and had great promise for further development and applications.     

基于量子点标记的适配体技术在分析检测中的研究进展

由于光学性质独特,量子点成为近年来发展起来的极具应用前景的半导体纳米材料,作为荧光标记物在生物和化学领域备受关注。随着生物技术的发展,适配体以其高特异性、强亲和力等特点被用作生物探针或生物传感元件,在分析检测中得到广泛应用。将量子点与适配体结合构建的纳米生物识别体系,互补结合适配体和量子点的特殊性质,可实现对靶标物质的超灵敏、高选择性及快速检测。本文概述了量子点的合成、修饰及其与适配体的偶联,重点介绍了近几年基于量子点标记的适配体技术在生物分子、病原微生物、细胞、真菌毒素等方面的应用,并展望了该技术在分析检测领域的发展趋势。     

双偏振极化干涉技术实时研究三磷酸腺苷与其适配体相互作用

利用双偏振极化干涉(Dual polarization interferometry,DPI)测量技术实时研究了三磷酸腺苷(ATP)与其适配体(ATP-binding aptamer, ABA)间的相互作用.将单链ABA固定在DPI氮化硅芯片上,采用DPI技术实时监测ATP与固定的ABA的相互作用过程中敏感层的质量、厚度、密度的变化.通过详细分析敏感层质量变化,得到ATP与ABA间的结合速率常数 (ka=4.66 × 10.3 L/(mol·s)、解离速率常数(kd =1.70 × 10.-2·s.-1)、结合常数 (KA=2.7 × 10.5 L/mol)和解离常数(KD =3.7 × 10.-6 mol/L).通过测定敏感层质量、厚度和密度随ATP浓度的变化,分别建立了测定ATP的方法,检出限(LOD, 3σ)分别为0.22 μmol/L(质量变化)、0.14 μmol/L(厚度变化)、0.32 μmol/L(密度变化).本研究利用DPI技术揭示了ABA与ATP相互作用中结构变化的实时信息,构建了新型ATP传感器,用于实际血清样品中ATP的检测,结果令人满意.     

Design of a dual aptamer-based recognition strategy for human matrix metalloproteinase 9 protein by piezoelectric biosensors

MMP-9, human matrix metalloproteinase 9, belongs to the family of zinc-dependent peptide-bond hydrolases and is involved in the degradation of the extracellular matrix (ECM). In clinics, it is well known that elevated MMP-9 serum levels are associated with cardiovascular dysfunctions, several aspects of the physiology and pathology of the central nervous system, neuropsychiatric disorders and degenerative diseases related to brain tumors, and excitotoxic/neuroinflammatory processes. Due to the large interest of diagnostics in this protein, efforts to set up sensitive methods to detect MMP-9 for early diagnosis of a number of metabolic alterations are rapidly increasing. In this panorama, biosensors could play a key role; therefore we explored for the first time the development of an aptamer-based piezoelectric biosensor for a sensitive, label free, and real time detection of MMP-9. The detecting strategy involved two different aptamers in a sandwich-like approach able to detect down to 100 pg mL⁻¹ (1.2 pM) of MMP-9 as detection limit in standard solution. As proof of principle, commercial serum was investigated in terms of possible interferents, their identification and role in MMP-9 detection. The estimated detection limit for MMP-9 is about 560 pg mL⁻¹ (6.8 pM) in untreated serum.     

Protein-aptamer binding studies using microchip affinity capillary electrophoresis

The use of traditional CE to detect weak binding complexes is problematic due to the fast-off rate resulting in the dissociation of the complex during the separation process. Additionally, proteins involved in binding interactions often nonspecifically stick to the bare-silica capillary walls, which further complicates the binding analysis. Microchip CE allows flexibly positioning the detector along the separation channel and conveniently adjusting the separation length. A short separation length plus a high electric field enables rapid separations thus reducing both the dissociation of the complex and the amount of protein loss due to nonspecific adsorption during the separation process. Thrombin and a selective thrombin-binding aptamer were used to demonstrate the capability of microchip CE for the study of relatively weak binding systems that have inherent limitations when using the migration shift method or other CE methods. The rapid separation of the thrombin-aptamer complex from the free aptamer was achieved in less than 10 s on a single-cross glass microchip with a relatively short detection length (1.0 cm) and a high electric field (670 V/cm). The dissociation constant was determined to be 43 nM, consistent with reported results. In addition, aptamer probes were used for the quantitation of standard thrombin samples by constructing a calibration curve, which showed good linearity over two orders of magnitude with an LOD for thrombin of 5 nM at a three-fold S/N.     

Detection of thrombin-specific oligonucleotides using quartz crystal microbalances coated with silica sol–gel glass thin films

A silica sol–gel glass containing thrombin was spin-coated on a quartz crystal and used to measure the binding of thrombin with thrombin-specific aptamers. The porous structures of the silica thin films were optimized to facilitate binding of the aptamers with thrombin by varying the solution pH and the concentration of polyethylene glycol. The hydrophilic silica sol–gel glass prevented aptamers from adsorbing nonspecifically and the absence of covalent bonding allowed the entrapped thrombin molecules to retain their reactivity. Further, the mass sensitivity of the quartz crystal microbalance was enhanced by encapsulating more thrombin molecules inside the porous sol–gel glasses.     

Development of an optical RNA-based aptasensor for C-reactive protein

The development of a RNA-aptamer-based optical biosensor (aptasensor) for C-reactive protein (CRP) is reported. CRP is an important clinical biomarker; it was the first acute-phase protein to be discovered (1930) and is a sensitive systemic marker of inflammation and tissue damage. It has also a prognostic value for patients with acute coronary syndrome. The average concentration of CRP in serum is 0.8 ppm and it increases in response to a variety of inflammatory stimuli, such as trauma, tissue necrosis, infection and myocardial infarction. The interaction between the 44-base RNA aptamer and the target analyte CRP is studied. In particular, the influence of the aptamer immobilization procedure (chemistry, length, concentration), as well as the binding conditions, i.e., the influence on the binding of different buffers, the presence of Ca²⁺ ion and the specificity (against human serum albumin) have been evaluated. Using the best working conditions, we achieved a detection limit of 0.005 ppm, with good selectivity towards human serum albumin. Some preliminary experiments in serum are reported. Figure The assay on the CM5 chip     

Enzyme Translocation-Mediated Signal Amplification for Spatially Selective Aptasensing of ATP in Inflammatory Cells

Amplified ATP imaging in inflammatory cells is highly desirable. However, the spatial selectivity of current amplification methods is limited, that is, signal amplification is performed systemically and not in a disease site-specific manner. Here we present a versatile strategy, termed enzymatically triggerable, aptamer-based signal amplification (ETA-SA), that enables inflammatory cell-specific imaging of ATP through spatially-resolved signal amplification. The ETA-SA leverages a translocated enzyme in inflammatory cells to activate DNA aptamer probes and further drive cascade reactions through the consumption of hairpin fuels, which, however, exerts no ATP response activity in normal cells, leading to a significantly improved sensitivity and spatial specificity for the inflammation-specific ATP imaging in vivo. Benefiting from the improved spatial selectivity, enhanced signal-to-background ratios were achieved for ATP imaging during acute hepatitis.